Status:
RECRUITING
IVM - Fresh ET (THE SAIGON PROTOCOL) Versus IVF - FET in PCOS Women
Lead Sponsor:
Mỹ Đức Hospital
Conditions:
Polycystic Ovary Syndrome (PCOS)
In Vitro Maturation of Oocytes
Eligibility:
FEMALE
18-42 years
Phase:
NA
Brief Summary
Assisted Reproductive Technologies (ART) aim to increase success rates while minimizing patient risks. For women with high AFC or PCOS, conventional IVF carries a high risk of OHSS (Ho et al., 2019). ...
Detailed Description
1. Screening for eligibility and randomization: Women who are potentially eligible are provided with information about the trial. Screening is done on the day of the first visit, and patients are give...
Eligibility Criteria
Inclusion
- Women aged 18 - 42 years old.
- Diagnosed with PCOS, followed Rotterdam 2003 criteria (Group TREP consensus workshop, 2004)
- Had fewer than three previous failed frozen embryo transfer (FET) cycles
- Transferred no more than two cleavage embryos or one good-quality blastocyst or no more than two poor-quality blastocysts.
- Agreeing to participate in the study
Exclusion
- Having allergy and contraindications for exogenous hormone administration (e.g., breast cancer, thromboembolic disease)
- Cycles with preimplantation genetic testing indication
- Oocyte donation cycles
- Having untreated uterine or adnexal abnormalities (e.g., intrauterine adhesions, unicornuate/ bicornuate/ arcuate uterus, large leiomyoma ≥5 cm in diameter; adenomyosis, endometrial polyp, hydrosalpinx).
Key Trial Info
Start Date :
September 22 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 15 2028
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT07171970
Start Date
September 22 2025
End Date
January 15 2028
Last Update
October 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IVFMD - My Duc Hospital
Ho Chi Minh City, Vietnam